![Graham Parry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Graham Parry
Technik-/Wissenschafts-/F&E-Leiter bei
ELECTRA THERAPEUTICS, INC.
Vermögen: 1 $ am 31.08.2026
Profil
Dr. Graham Parry is a Chief Scientific Officer at Electra Therapeutics, Inc. Dr. Parry was previously employed as an Executive Vice President-Translational Sciences by Star Therapeutics, Inc., a Senior Vice President-Translational Sciences by Third Harmonic Bio, Inc., a Vice President-Technical Operations by True North Therapeutics, Inc., a Biology Director by Attenuon, LLC, and a Principal by Motility, Inc. He received his undergraduate degree from Brunel University London and a doctorate degree from the University of London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.09.2026 | 85.504 ( 0,22 % ) | 1 $ | 31.08.2026 |
Aktive Positionen von Graham Parry
| Unternehmen | Position | Beginn |
|---|---|---|
| ELECTRA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2023 |
Ehemalige bekannte Positionen von Graham Parry
| Unternehmen | Position | Ende |
|---|---|---|
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Corporate Officer/Principal | 01.12.2023 |
| THIRD HARMONIC BIO, INC. | Corporate Officer/Principal | 01.12.2022 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 |
Motility, Inc. | Corporate Officer/Principal | - |
Attenuon, LLC
 Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Corporate Officer/Principal | - |
Ausbildung von Graham Parry
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
21
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Brunel University
 Brunel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Attenuon, LLC
Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Motility, Inc. | |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological and cancer diseases | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Health Technology |
